Drugs anti-HIV: Past, present and future perspectives;Drogas anti-VIH: Passado, presente e perspectivas futuras

Quimica Nova

Volumn 26, Issue 3, 2003, Pages 366-372

  De Souza, Marcus Vinícius Nora ^a   De Almeida, Mauro Vieira ^b  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF JUIZ DE FORA   (Brazil)

Author keywords

AIDS; New Anti HIV drugs; Replicative cycle

Indexed keywords

1 (3 CYCLOPENTENYLMETHYL) 6 (3,5 DIMETHYLBENZOYL) 5 ETHYLURACIL; 1,1' [1,4 PHENYLENEBIS(METHYLENE)]BIS(1,4,8,11 TETRAAZACYCLOTETRADECANE); 1,3 BIS(3 AMINOBENZYL) 4,7 DIBENZYL 2,3,4,5,6,7 HEXAHYDRO 5,6 DIHYDROXY 1H 1,3 DIAZEPIN 2 ONE; 6 CHLORO 2 [(1 FURO[2,3 C]PYRIDIN 5 YLETHYL)THIO] 4 PYRIMIDINAMINE; 6 CHLORO 4 (2 CYCLOPROPYLVINYL) 3,4 DIHYDRO 4 TRIFLUOROMETHYL 2(1H) QUINAZOLINONE; ABACAVIR; ADEFOVIR DIPIVOXIL; AMPRENAVIR; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; CANANOLIDA A; CAPRAVIRINE; DELAVIRDINE; DIDANOSINE; EFAVIRENZ; EMIVIRINE; EMTRICITABINE; INDINAVIR; L 731988; LAMIVUDINE; LOPINAVIR; N [4 CHLORO 3 (3 METHYL 2 BUTENYLOXY)PHENYL] 2 METHYL 3 FURANCARBOTHIOAMIDE; N [4 [[[6,7 DIHYDRO 2 (4 METHYLPHENYL) 5H BENZOCYCLOHEPTEN 8 YL]CARBONYL]AMINO]BENZYL] N,N DIMETHYL 2H TETRAHYDROPYRAN 4 AMINIUM CHLORIDE; N' [2 HYDROXY 3 (N METHOXYCARBONYL TERT LEUCYLAMINO) 4 PHENYLBUTYL] NALPHA METHOXYCARBONYL N' [4 (2 PYRIDYL)BENZYL] TERT LEUCYLHYDRAZIDE; NELFINAVIR; NEVIRAPINE; PNU 14271; PROTEINASE INHIBITOR; R 165335; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; STAVUDINE; TENOFOVIR DISOPROXIL; TIPRANAVIR; TMC 125; UNCLASSIFIED DRUG; UNINDEXED DRUG; ZALCITABINE; ZIDOVUDINE;

ANTIVIRAL ACTIVITY; CLINICAL TRIAL; DNA INTEGRATION; DRUG MECHANISM; DRUG RESEARCH; DRUG TARGETING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; RECEPTOR BLOCKING; REVIEW; RNA TRANSCRIPTION; TRANSACTIVATION; VIRUS ADSORPTION; VIRUS ASSEMBLY; VIRUS CELL INTERACTION; VIRUS ENVELOPE; VIRUS REPLICATION;

EID: 0038043238     PISSN: 01004042     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0100-40422003000300014     Document Type: Review

References (52)

1. nd ed., Wiley: New York, 1988.
2. Barre-Sinoussi, F.; Cherman, J. C.; Rey, F.; Nugeyre, M. T.; Charmaret, S.; Gruest, J.; Dauguet, C.; Axler-Blin, C.; Brun-Vezinet, F.; Rouzioux, C.; Rosenbaum, W.; Montagnier, L.; Science 1983, 220, 868.
3. Johnson, R.; Chenoweth, D.; J. Biol. Chem. 1989, 260, 7161.
4. Gupta, C.; Costello, C.; Khorana, H.; Proc. Natl. Acad. Sci. U.S.A. 1979, 76, 2595.
5. Heyward, W.; Curran, J.; Pour la Science 1988, 134, 48.
6. Grmek, M. D.; La Recherche 1991, 234, 985.
7. http://www.ordembiologos/Biologias/Nl.hmtl, acessada em Junho 2002.
8. De Clercq, E.; La Recherche 1986, 29, 1561.
9. Schild, G. C.; Minor, P. D.; Lancet 1990, 335, 1081.
10. De Clercq, E.; Med. Mal. Inject. 2000, 30, 421.
11. Horwitz, J. P.; Chua, J.; Noel, M.; J. Org. Chem. 1964, 29, 2076.
12. Yarchan, R.; Mitsuya, H.; Broder, S.; Matthews, T.; Bolognesi, D.; Pour La Science 1988, 134, 94.
13. Naor, M.; Litterst, C.; McGowan, J.; Antiviral Res. 1990, 14, 125.
14. Herdewijn, P.; De Clercq, E.; Design of Anti-Aids Drugs; Ed. Elsevier Science: Amsterdan, 1990, p. 141-171.
15. Goulaouic-Dubois, C.; Tese de Doutorado; Universidade Paris XI, França, 1994
16. Mitsuya, H.; Broder, S.; Proc. Natl. Acad. Sci. U.S.A. 1986, 83, 1911.
17. Yarchoan, R.; Mitsuya, H.; Thomas, R. V.; Pluda, J. M.; Hartman, N. R.; Perno, C. F.; Marczyk, K. S.; Allain, J. P.; Jonhs, D. G.; Broder, S.; Science 1989, 245, 412.
18. Lin, T. S.; Schinazi, R. F.; Prusoff, W. H.; Biochem. Pharmacol. 1987, 36, 2713.
19. Mitsuya, H.; Broder, S.; Nature 1987, 325, 773.
20. Tavel, J. A.; Miller, K. D.; Masur, H.; Clin. Infect. Dis. 1999, 28, 643.
21. De Clercq, E.; Antiviral Res. 1989, 12, 1.
22. De Clercq, E.; Biochim. Biophys. Acta 2002, 62127.
23. De Clercq, E.; J. Clin. Virol. 2001, 22, 73.
24. Li, X.; Chan, K.; Adv. Drug Delivery Rev. 1999, 39, 81.
25. De Clercq, E.; Int. J. Antimicrob. Agents 1997, 9, 21.
26. Huff, J. R.; Bioorg. Med. Chem. 1999, 7, 3667.
27. Schultze, L. M.; Chapman, H. H.; Dubree, J. P.; Jones, R. J.; Kent, K. M.; Lee, T. T.; Louie, M. S.; Postich, M. J.; Prisbe, E. J.; Rodhloff, J. C.; Yu, R. H.; Tetrahedron Lett. 1998, 39, 1853.
28. De Clercq, E.; J. Med. Chem. 1995, 38, 2491.
29. Clair, S.; Richards, C. A.; Spector, T.; Weinhold, K. J.; Miller, W. H.; Langlois, A. J.; Furman, P. A.; Antimicrob. Agents Chemother. 1987, 31, 1972.
30. Huang, P.; Farquhar, D.; Plunkett, W.; J. Biol. Chem. 1990, 265, 11914; Ikemoto, T.; Nishiguchi, A.; Mitsudera, H.; Wakimasu, M.: Tomimatsu, K.; Tetrahedroll 2001, 57, 1525.
31. Huang, P.; Farquhar, D.; Plunkett, W.; J. Biol. Chem. 1990, 265, 11914; Ikemoto, T.; Nishiguchi, A.; Mitsudera, H.; Wakimasu, M.: Tomimatsu, K.; Tetrahedroll 2001, 57, 1525.
32. Grozinger, K. G.; Fuchs, V.; Hargrave, S.; Mauldin, J.; Vitous, C.; J. Heterocycl. Chem. 1995, 32, 259.
33. Cocuzza, A. J.; Chidester, D. R.; Cordova, B. C.; Klabe, R. M.; Jeffrey, S.; Diamond, S.; Weigelt, C. A.; Ko, S. S.; Bacheler, L. T.; Erickson-Viitanen, S. K.; Rodgers, J. D.; Bioorg. Med. Chem. Lett. 2001, 11, 1389.
34. Cocuzza, A. J.; Chidester, D. R.; Cordova, B. C.; Jeffrey, S.; Parsons, R. L.; Ko, S. S.; Bacheler, L. T.; Erickson-Viitanen, S; Trainor, G. L.; Bioorg. Med. Chem. Lett. 2001, 11, 1177.
35. De Clercq, E.; Antiviral Res. 1998, 38, 153.
36. Ren, J.; Esnouf, R. M.; Hopkins, A. L.; Warren, J.; Balzarini, J.; Stuart, D. I.; Stammers, D. K.; Biochemistry 1998, 37, 14394.
37. Buckheit Jr., R. W.; Watson, K.; Fliakas-Boltz, V.; Russell, J.; Loftus, T. L.; Osterlin, M. C.; Turpin, J. A.; Pallansch, L. A.; White, E. L.; Lee, J. W.; Lee, S. H.; Oh, J. W.; Kwon, H. S.; Chung, S. G.; Cho, E. H.; Antimicrob. Agents Chemother. 2001, 45, 393.
38. Wishka, D. G.; Graber, D. R.; Kopta, L. A.; Olmsted, R. A.; Friis, J. M.; Hosley, J. D.; Adams, W. J.; Seest, E. P.; Castle, T. M.; Dolak, L. A.; Keiser, B. J.; Yagi, Y.; Jeganathan, A.; Schlachter, S. T.; Murphy, M. J.; Cleek, G. J.; Nugent, R. A.; Poppe, S. M.; Swaney, S. M.; Han, F.; Watt, W.; White, W. L.; Poel, T. J.; Thomas, R. C.; Voorman, R. L.; Stefanski, K. J.; Stehle, R. G.; Tarpley W. G.; Morris, J.; J. Med. Chem. 1998, 41, 1357.
39. Tanaka, T.; Kumamoto, T.; Ishikawa, T.; Tetrahedron Lett. 2000, 41, 10229.
40. Fuller, R. W.; Bokesch, H. R.; Gustafson, K. R.; McKeene, T. C.; Cardelina II, J. H.; McMahon, J. B.; Cragg, G. M.; Soejarto, D. D.; Boyd, M. R.; Bioorg. Med. Chem. Lett. 1994, 16, 1961.
41. Fox, M. E.; Lennon, I. C.; Meek, G.; Tetrahedron Lett. 2002, 43, 2899.
42. Kucherenko, A.; Flavin, M. T.; Boulanger, W. A.; Khilevich, A.; Shone, R. L.; Rizzo, J. D.; Sheinkman A.; K.; Xu, Z. Q.; Tetrahedron Lett. 1995, 36, 5475.
43. Brown, W. M.; Curr. Opin. Anti-Infect. Invest. Drugs 2000, 2, 286.
44. Golebiewski, W. M.; Bader, J. P.; Cushman, M.; Bioorg. Med. Chem. Lett. 1993, 3, 1739.
45. Kannan, A.; De Clercq, E.; Pannecouque, C.; Witvrouw, M.; Hartman, T. L.; Turpin, J. A.; Bruckheit Jr., R. W.; Cushman, M.; Tetrahedron 2001, 57, 9385.
46. Ikemoto, T.; Nishiguchi, A.; Mitsudera, H.; Wakimasu, M.; Tomimatsu, K.; Tetrahedron 2001, 57, 1525.
47. Vandevelde, M.; Witvrouw, M.; Schmidt, J. C.; Sprecher, S.; De Clerq, E.; Tassignon, J. P.; AIDS Res. Hum. Retroviruses 1996, 12, 567.
48. King, P. J.; Robinson Jr., W. E.; J. Virol. 1998, 72, 8420.
49. Hazuda, D. J.; Felock, P.; Witmer, M.; Wolfe, A.; Stillmock, K.; Grobler, J. A.; Espeseth, A.; Gabryelski, L.; Schleif, W.; Blau, C.; Miller, M. D.; Science 2000, 287, 646.
50. Okamoto, H.; Cujec, T. P.; Okamoto, M.; Peterlin, B. M.; Baba, M.; Okamoto, T.; Virology 2000, 272, 402.
51. Turpin, J. A.; Bruckheit Jr., R. W.; Derse, D.; Hollingshead, M.; Williamson, K.; Palamone, C.; Osterling, M. C.; Hill, S. A.; Grahan, L.; Schaeffer, C. A.; Bu, M.; Huang, M.; Cholody, W. M.; Michejda, C. J.; Rice, W. G.; Antimicrob. Agents Chemother. 1998, 42, 487.
52. Murti, K. K.; Dubay, M.; McClure, C.; Brizuela, L.; Boisclair, M. D.; Worland, P. J.; Mansuri, M. M.; Pal; Bioorg. Med. Chem. Lett. 2000, 10, 1037.